Zinc mono-therapy in pre-symptomatic chinese children with Wilson Disease: A single center, retrospective study

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Abuduxikuer, Kuerbanjiang ^a   Wang, Jian She ^b  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPPER; GAMMA GLUTAMYLTRANSFERASE; GLUCONATE ZINC; PENICILLAMINE; ZINC;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CHILD; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER METABOLISM; DIARRHEA; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PRESCHOOL CHILD; PROTEINURIA; RETROSPECTIVE STUDY; SCHOOL CHILD; VOMITING; WILSON DISEASE; ZINC BLOOD LEVEL;

ADOLESCENT; ASYMPTOMATIC DISEASES; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; COPPER; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER FUNCTION TESTS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ZINC;

EID: 84897505209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086168     Document Type: Article

References (37)

1. Brewer GJ, Yuzbasiyan-Gurkan V (1992) Wilson disease. Medicine 71: 139-164.
2. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5: 327-337. (Pubitemid 23351302)
3. Danks DM (1995) Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, et al. eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edition. New York: McGraw Hill: 2211-2235.
4. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, et al. (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23: 139-142. (Pubitemid 37265785)
5. Koppikar S, Dhawan A (2005) Evaluation of the scoring system for the diagnosis of Wilson's disease in children. Liver Int 25: 680-681.
6. Medici V, Rossaro L, Sturniolo GC (2007) Wilson disease-a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 39: 601-609. (Pubitemid 46888204)
7. European Association for Study of Liver (2012) EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 56: 671-685.
8. Roberts EA, Schilsky ML (2008) American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 47: 2089-2111.
9. Hoogenraad TU (2006) Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 28: 141-146.
10. Brewer GJ (2001) Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother 2: 1473-1477.
11. Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH (2009) Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 29: 947-958.
12. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, et al. (1998) Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 132: 264-278. (Pubitemid 28490259)
13. Hoogenraad TU, Van Hattum J, Van den Hamer CJ (1987) Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 77: 137-146. (Pubitemid 17231288)
14. Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, et al. (2005) Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med 145: 139-143. (Pubitemid 40432363)
15. Wu ZY, Lin MT, Murong SX, Wang N (2003) Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease. Arch Neurol 60: 737-741.
16. Czlonkowska A, Gajda J, Rodo M (1996) Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 243: 269-273. (Pubitemid 26071990)
17. Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, et al. (2006) Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 40: 936-941. (Pubitemid 44690770)
18. Hoogenraad TU, Koevoet R, de RuyterKorver EG (1979) Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 18: 205-211. (Pubitemid 9237779)
19. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ (1992) Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 120: 380-386.
20. Lee DY, Brewer GJ, Wang YX (1989) Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model. J Lab Clin Med 114: 639-645. (Pubitemid 20018041)
21. Goering PL, Tandon SK, Klaassen CD (1985) Induction of hepatic metallothionein in mouse liver following administration of chelating agents. Toxicol Appl Pharmacol 80: 467-72. (Pubitemid 15225519)
22. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P (1983) Oral zinc therapy for Wilson's disease. Ann Intern Med 99: 314-319.
23. Hoogenraad TU (1998) Zinc treatment of Wilson's disease. J Lab Clin Med 132: 240-241.
24. Brewer GJ, Dick RD, Johnson VD, Fink JK, Kluin KJ, et al. (2001) Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 137:191-198. (Pubitemid 32203199)
25. Brewer GJ, Yuzbasiyan-Gurkan V, Dick R (1990) Zinc therapy of Wilson's disease VIII. Dose response studies. Trace Elem Exp Med 3: 227-234. (Pubitemid 20348078)
26. Mishra D, Kalra V, Seth R (2008) Failure of prophylactic zinc in Wilson disease. Indian Pediatr 45: 151-153. (Pubitemid 351340736)
27. Walshe JM, Munro NAR (1995) Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. Arch Neurol 52: 10-11.
28. Lang CJG, Rabas-Kolominsky AE, Konras G, Konig HI (1933) Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol 50: 1007-1008.
29. Castilla-Higuero L, Romero-Gomez M, Suarez E, Castro M (2000) Acute hepatitis after starting zinc therapy in a patient with presymptomatic Wilson's disease. Hepatology 32: 877.
30. Mulder TP, Janssens AR, Verpaget HW, van Hattum, Lamers CB (1992) Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer. J Hepatol 16: 346-350. (Pubitemid 23013228)
31. Friedman LS (1993) Zinc in the treatment of Wilson's disease: how it works. Gastroenterology 104: 1566-1568.
32. Yuzbasiyan-Gurkan V, Brewer GJ, Abrams GD, Main B, Giacherio D (1989) Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. J Lab Clin Med 114: 520-526. (Pubitemid 19285570)
33. Sadighi A, Roshan MM, Moradi A, Ostadrahimi A (2008) The effects of zinc supplementation on serum zinc, alkaline phosphatase activity and fracture healing of bones. Saudi Med J 29: 1276-1279.
34. Linn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ (2009) Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 50: 1442-1452.
35. Mizuochi T, Kimura A, Shimizu N, Nishiura H, Matsushita M, et al. (2011) Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease. J Pediatr Gastroenterol Nutr 53: 365-357.
36. Brewer GJ (2001) Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management. Boston: Kluwer Academic Publishers.
37. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y (1994) Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 123: 849-858.